Abstract: Disclosed is a method to identify compounds useful for reducing insulin resistance in a patient, and particularly a patient that has insulin resistance associated with obesity and/or type II diabetes. Also disclosed is a method of reducing insulin resistance in a patient by administering a compound identified using the method of the invention, and particularly, by administering an antagonist of melanocortin stimulating hormone (MSH) biological activity.
Type:
Application
Filed:
January 23, 2004
Publication date:
September 9, 2004
Applicants:
Eleanor Roosevelt Institute, Olkahoma Medical Research Foundation